Long-time follow-up of the node negative breast cancer patients before treatment evaluated with sentinel node biopsy alone following neoadjuvant chemotherapy.
(SAN ANTONIO BREAST CANCER SYMPOSIUM 2014)
Impact of claudin-3 and basal-markers expressions on pathological complete response to neoadjuvant chemotherapy and prognosis in triple negative breast cancer
(SAN ANTONIO BREAST CANCER SYMPOSIUM 2013)